Jim Cramer Said Sandisk Stock Performance is Befuddling & Discussed These 17 Stocks 

Page 11 of 11

6. CVS Health Corporation (NYSE:CVS)

Number of Hedge Fund Holdings in Q4 2025: 88

CVS Health Corporation (NYSE:CVS) continues to be favored by Jim Cramer in the pharmaceutical retailer space. Its shares are up by 30% over the past year and by 8.4% year-to-date. Cramer has discussed CVS Health Corporation (NYSE:CVS) several times over the past couple of months and praised the firm’s management at being able to operate well in an otherwise tumultuous industry. Baird raised the share price target to $94 from $92 and kept an Outperform rating on the stock on April 15th. Other analysts had discussed CVS Health Corporation (NYSE:CVS)’s settlement with the FTC as part of their earlier coverage. In this appearance, Cramer predicted that the firm’s upcoming quarter results would be good. He was proven right as CVS Health Corporation (NYSE:CVS) posted $100.43 billion in revenue and $2.57 in earnings per share to beat analyst estimates of $95.09 billion and $2.20.

“Rite Aid disappeared, Walgreens seems to be going away. CVS has a good quarter coming up, I think, but that’s because of Aetna.”

While we acknowledge the potential of CVS to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CVS and that has 100x upside potential, check out our report about the cheapest AI stock.

Click to continue reading and see Jim Cramer Said Sandisk Stock Performance is Befuddling & Discussed These 5 Stocks.

Disclosure: None. Follow Insider Monkey on Google News.

Page 11 of 11